KORU Medical Systems, Inc. (KRMD) 8-K Current Report: March 16, 2026
Filed: March 16, 2026
Health Care
Surgical & Medical Instruments & ApparatusKORU Medical Systems, Inc. (KRMD) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
KORU Medical Systems, Inc. 8-K Mar 16, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • CEO Linda Tharby retiring June 30, 2026; replaced by Kalbermatten (current exec) as President March 15, CEO July 1 — planned succession, not abrupt departure
- • Kalbermatten base salary steps up from $450K to $525K on July 1, 2026; 2026 LTI target $1,250,000 plus one-time $1,250,000 Promotion PSU tied to revenue growth (75%) and market cap (25%)
- • Tharby advisory period through Dec 31, 2026 at 50% of prior base salary; 220,000 PSUs vested on 2025 performance, 200,000 PSUs previously cancelled for missing thresholds — signals mixed recent performance
- • Tharby irrevocably waived Change of Control vesting acceleration on trailing revenue run-rate provision — reduces potential M&A payout overhang for acquirers
- • Kalbermatten severance: 12-month salary continuation + 100% bonus target if terminated without Cause; full equity acceleration on Change of Control — standard but noteworthy given $2.5M+ in new equity grants
Other KORU Medical Systems, Inc. 8-K Filings
Get deeper insights on KORU Medical Systems, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.